Volume 4, Issue 4 ( Journal of Clinical and Basic Research (JCBR) 2020)                   jcbr 2020, 4(4): 1-7 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zanganeh M, Mazloomi S N, Alijanpour E, Jabbari A. Curcumin and Pregnancy Problems: a Narrative Review of Curcumin's Effect on Preeclampsia. jcbr. 2020; 4 (4) :1-7
URL: http://jcbr.goums.ac.ir/article-1-283-en.html
1- Department of Gynecology and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran
2- Department of Food Science and Technology, Gorgan University of Agricultural and Natural Sciences, Gorgan, Iran
3- Department of Anesthesiology and Critical Care Medicine, Babol University of Medical Sciences, Babol, Iran
4- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran,5. Department of Anesthesiology and Critical Care Medicine, Golestan University of Medical Sciences, Gorgan, Iran , 6. Clinical Research Development Unit, 5 Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran
Abstract:   (661 Views)

Curcumin is a bright yellow chemical produced by Curcuma longa, a member of the ginger family (Zingiberaceae). This compound is mainly extracted from fat-soluble, polyphenolic pigments known as curcuminoids. Curcumin has been used as an herbal supplement, cosmetic ingredient and spice. Curcumin may be useful in the prevention and treatment of inflammation-associated adverse pregnancy outcomes mainly due to its anti-inflammatory properties, which are exerted through reduction of pro-inflammatory factors, macrophage infiltration and NF-jB activation. This review provides a brief overview of the efficacy of curcumin for treatment of preeclampsia.

Full-Text [PDF 241 kb]   (168 Downloads) |   |   Full-Text (HTML)  (109 Views)  
Article Type: Research | Subject: Basic medical sciences
Received: 2021/01/3 | Accepted: 2020/12/10 | Published: 2020/12/10

1. Wu B-N, Huang Y-C, Wu H-M, Hong S-J, Chiang L-C, Chen J. A highly selective β1-adrenergic blocker with partial β2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch. Journal of cardiovascular pharmacology. 1998;31(5):750-7. [View at Publisher] [DOI] [PubMed] [Google Scholar]
2. Astin JA. Why patients use alternative medicine: results of a national study. Jama. 1998;279(19):1548-53. [View at Publisher] [DOI] [PubMed] [Google Scholar]
3. Yilmaz MB, Yontar OC, Turgut OO, Yilmaz A, Yalta K, Gul M, et al. Herbals in cardiovascular practice: are physicians neglecting anything? International journal of cardiology. 2007;122(1):48-51. [View at Publisher] [DOI] [PubMed] [Google Scholar]
4. Kim J-D, Kang S-M, Park M-Y, Jung T-Y, Choi H-Y, Ku S-K. Ameliorative anti-diabetic activity of dangnyosoko, a Chinese herbal medicine, in diabetic rats. Bioscience, biotechnology, and biochemistry. 2007;71(6):1527-34. [View at Publisher] [DOI] [PubMed] [Google Scholar]
5. Asadi-Samani M, Bahmani M, Rafieian-Kopaei M. The chemical composition, botanical characteristic and biological activities of Borago officinalis: a review. Asian Pacific journal of tropical medicine. 2014;7s1:S22-8. [View at Publisher] [DOI] [PubMed] [Google Scholar]
6. Asadbeigi M, Mohammadi T, Rafieian-Kopaei M, Saki K, Bahmani M, Delfan M. Traditional effects of medicinal plants in the treatment of respiratory diseases and disorders: an ethnobotanical study in the Urmia. Asian Pacific journal of tropical medicine. 2014;7s1:S364-8. [View at Publisher] [DOI] [PubMed] [Google Scholar]
7. Karamati SA, Hassanzadazar H, Bahmani M, Rafieian-Kopaei M. Herbal and chemical drugs effective on malaria. Asian Pacific Journal of Tropical Disease. 2014;4:S599-S601. [View at Publisher] [DOI] [Google Scholar]
8. Addo V. Herbal medicines: socio-demographic characteristics and pattern of use by patients in a tertiary obstetrics and gynaecology unit. Journal of Science and Technology (Ghana). 2007;27(3):149-55. [View at Publisher] [DOI] [Google Scholar]
9. Kunnen A, van Pampus MG, Aarnoudse JG, van der Schans CP, Abbas F, Faas MM. The effect of Porphyromonas gingivalis lipopolysaccharide on pregnancyin the rat. Oral Dis. 2014;20(6):591-601. [View at Publisher] [DOI] [Google Scholar]
10. Keihanian F, Saeidinia A, Bagheri RK, Johnston TP, Sahebkar A. Curcumin, hemostasis, thrombosis and coagulation. Journal of cellular physiology. 2017. [View at Publisher] [DOI] [PubMed] [Google Scholar]
11. Ghosh SS, Gehr TW, Ghosh S. Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules. 2014;19(12):20139-56. [View at Publisher] [DOI] [PubMed] [Google Scholar]
12. Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci. 2014;19(6):933-9. [View at Publisher] [DOI] [PubMed] [Google Scholar]
13. Cheppudira B, Fowler M, McGhee L, Greer A, Mares A, Petz L, Devore D, Loyd DR, Clifford JL. Curcumin: a novel therapeutic for burn pain and wound healing. Expert Opin Investig Drugs. 2013;22(10):1295-303. [View at Publisher] [DOI] [PubMed] [Google Scholar]
14. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. CURRENT SCIENCE-BANGALORE-. 2004;87:44-53. [View at Publisher] [Google Scholar]
15. Hansson SR, Chen Y, Brodszki J, Chen M, Hernandez-Andrade E, Inman J, et al. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Molecular human reproduction. 2006;12(3):169-79. [View at Publisher] [DOI] [PubMed] [Google Scholar]
16. Yeni CM, Fauziah PN, Maskoen AM, Ruslami R, Mose J. Effect of Curcumin in Decreasing MDA Level in Preeclampsia-Induced Human Umbilical Vein Endothelial Cell (HUVEC). International Journal of PharmTech Research. 2017;10(2):69-73. [View at Publisher] [DOI] [Google Scholar]
17. Rahardjo B, Widjajanto E, Sujuti H, Keman K. Curcumin decreased level of proinflammatory cytokines in monocyte cultures exposed to preeclamptic plasma by affecting the transcription factors NF-κB and PPAR-γ. Biomarkers and Genomic Medicine. 2014;6(3):105-15. [View at Publisher] [DOI] [Google Scholar]
18. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-18. [View at Publisher] [DOI] [PubMed] [Google Scholar]
19. Gong P, Liu M, Hong G, Li Y, Xue P, Zheng M, et al. Curcumin improves LPS-induced preeclampsia-like phenotype in rat by inhibiting the TLR4 signaling pathway. Placenta. 2016;41:45-52. [View at Publisher] [DOI] [PubMed] [Google Scholar]
20. Gan Y, Zheng S, Baak JP, Zhao S, Zheng Y, Luo N, et al. Prediction of the anti-inflammatory mechanisms of curcumin by module-based protein interaction network analysis. Acta Pharmaceutica Sinica B. 2015;5(6):590-5. [View at Publisher] [DOI] [PubMed] [Google Scholar]
21. Rajitha B, Belalcazar A, Nagaraju GP, Shaib WL, Snyder JP, Shoji M, et al. Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer. Cancer letters. 2016;373(2):227-33. [View at Publisher] [DOI] [PubMed] [Google Scholar]
22. Shaw J, Tang Z, Schneider H, Saljé K, Hansson SR, Guller S. Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-α: Implications in preeclampsia (PE). Placenta. 2016;43:1-8. [View at Publisher] [DOI] [PubMed] [Google Scholar]
23. Maradana MR, Thomas R, O'Sullivan BJ. Targeted delivery of curcumin for treating type 2 diabetes. Mol Nutr Food Res. 2013;57(9):1550-6. [View at Publisher] [DOI] [PubMed] [Google Scholar]
24. Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos G, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. Journal of Crohn's and Colitis. 2015;9(1):86-106. [View at Publisher] [DOI] [PubMed] [Google Scholar]
25. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Molecular pharmaceutics. 2007;4(6):807-18 [View at Publisher] [DOI] [PubMed] [Google Scholar]
26. Ganiger S, Malleshappa H, Krishnappa H, Rajashekhar G, Rao VR, Sullivan F. A two generation reproductive toxicity study with curcumin, turmeric yellow, in Wistar rats. Food and chemical toxicology. 2007;45(1):64-9. [View at Publisher] [DOI] [PubMed] [Google Scholar]
27. Zhou J, Miao H, Li X, Hu Y, Sun H, Hou Y. Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt. Inflamm. Res. 66, 177-185 (2017). [View at Publisher] [DOI] [PubMed] [Google Scholar]
28. Qian L, Wang H, Wu F, Li M, Chen W, Lv L. Vitamin D3 alters Toll-like receptor 4 signaling in monocytes of pregnant women at risk for preeclampsia. International journal of clinical and experimental medicine. 2015;8(10):18041-9. [View at Publisher] [DOI] [PubMed] [Google Scholar]
29. Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Annals of internal medicine. 2014;160(10):695-703. [View at Publisher] [DOI] [PubMed] [Google Scholar]
30. Ganjali S, Sahebkar A, Mahdipour E, Jamialahmadi K, Torabi S, Akhlaghi S, et al. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. TheScientificWorldJournal. 2014;2014:898361. [View at Publisher] [DOI] [PubMed] [Google Scholar]
31. Yekollu SK, Thomas R, O'Sullivan B. Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice. Diabetes. 2011;60(11):2928-38. [View at Publisher] [DOI] [PubMed] [Google Scholar]
32. Hartley JD, Ferguson BJ, Moffett A. The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia. American journal of obstetrics and gynecology. 2015;213(3):268-77. [View at Publisher] [DOI] [PubMed] [Google Scholar]
33. Vizi ES, Szelényi J, Selmeczy ZS, Papp Z, Németh ZH, Haskó G. Enhanced tumor necrosis factor-alpha-specific and decreased interleukin-10-specific immune responses to LPS during the third trimester of pregnancy in mice. The Journal of endocrinology. 2001;171(2):355-61. [View at Publisher] [DOI] [PubMed] [Google Scholar]
34. Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA, Graham CH. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. The Journal of experimental medicine. 2014;211(1):165-79. [View at Publisher] [DOI] [PubMed] [Google Scholar]
35. Fadinie W, Lelo A, Wijaya DW, Lumbanraja SN. Curcumin and its effect on preeclampsia: as antii-inflammatory, analgesic, and anticoagulant. International Journal of Current Pharmaceutical Research. 2020;12(2):43-47. [DOI]

Add your comments about this article : Your username or Email:

© 2021 CC BY-NC 4.0 | Journal of Clinical and Basic Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).